Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage
about
Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapyThe MMS22L-TONSL complex mediates recovery from replication stress and homologous recombinationDNA-PK-dependent RPA2 hyperphosphorylation facilitates DNA repair and suppresses sister chromatid exchangeTumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activationThe cohesin complex is required for the DNA damage-induced G2/M checkpoint in mammalian cellsMiz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stressTargeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugsThe replication fork: understanding the eukaryotic replication machinery and the challenges to genome duplicationClaspin promotes normal replication fork rates in human cellsThe combined status of ATM and p53 link tumor development with therapeutic responseClaspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activationTargeting DNA Replication Stress for Cancer TherapyRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsRad53-Mediated Regulation of Rrm3 and Pif1 DNA Helicases Contributes to Prevention of Aberrant Fork Transitions under Replication Stress.Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing geneGli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitorsRegulation of Claspin degradation by the ubiquitin-proteosome pathway during the cell cycle and in response to ATR-dependent checkpoint activationSpy1 expression prevents normal cellular responses to DNA damage: inhibition of apoptosis and checkpoint activationNovel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy?Checkpoint kinase 1 in DNA damage response and cell cycle regulationThe cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial designRoles of Chk1 in cell biology and cancer therapyHCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stabilityDNA damage response genes and the development of cancer metastasisToxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpointCircumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cellsDNA replication stress mediates APOBEC3 family mutagenesis in breast cancerThe effect of the intra-S-phase checkpoint on origins of replication in human cells.The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.H2AX is required for cell cycle arrest via the p53/p21 pathwayDNA damage-induced cell death is enhanced by progression through mitosisCentromere fragmentation is a common mitotic defect of S and G2 checkpoint override.Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell deathRPA2 is a direct downstream target for ATR to regulate the S-phase checkpoint.Global regulation of genome duplication in eukaryotes: an overview from the epifluorescence microscope.Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45.ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability.
P2860
Q21245716-59D74D73-9658-421B-B763-5F358204E07AQ24306030-D60D1887-07E5-4FA9-8A2D-72D24C4F6512Q24311527-E9865AEA-4F24-460B-ABB6-A891CEBBE0BCQ24311887-934731B7-F34C-4029-82FD-010D354652EAQ24317260-9D40E9E1-57E5-4BE1-8F5A-CDD3ADACD7D7Q24323957-17048E64-9DA0-48BE-8094-C23EC5A9DA9EQ24537422-C073D827-239D-45B3-8757-74A8DDDDCFE3Q24610287-0DF9BC97-1476-40BF-A475-0CF969CAB428Q24633729-99D4FEAB-ADD2-45D8-B4A1-0A9F1F7F0C4EQ24649012-D77D4638-5B03-4160-AC66-A7EF798D1382Q24652535-658FE8FE-65F4-48B5-BBBB-69FFABD11A72Q24670580-822A8EAF-7C7C-4092-B049-21740D3B99E2Q26739923-B50A7643-0509-4C50-B711-EBE26B7BE126Q27009016-14715689-2D99-45F5-A934-1638FA9BF1B1Q27930928-4FE4A4E6-AA74-4546-9ED8-B299C9A77CECQ28242019-9CA0197D-7B47-4E27-813A-9CD4D5BC6D02Q28248615-1C606A33-5A87-4300-8480-54BB90794BBDQ28250925-A776D50E-8FBF-4290-9868-77744250EFC7Q28261764-54B98984-CB51-4FDF-B7DB-B9C6AB407849Q28262425-A6E43F9C-631F-465A-AD38-0E5EC74C85E5Q28287480-FED9FA04-9C8A-4188-82FA-302400C0AEEFQ28289090-28C27330-0AB3-4B8F-BA6B-9D670C1F98A9Q28289548-5503B077-8ADB-41A6-99F8-7C3FD6DEAC8DQ28294885-055DA627-636F-4644-9D53-1E83F35D00ABQ28388312-6E9C5C0C-1A63-40A5-80E1-C62DD42D3916Q28486314-9A6CEE54-C297-4A29-AC9C-E779A5C3095FQ28540339-1439A864-D78A-464C-83FD-AC42640B62BBQ28830105-9A53B3F4-28E3-48DC-BCA6-D87F474705CBQ30430707-A00D45D5-6F04-4500-9F5B-1A186E61C4E4Q30486781-77165510-0646-434C-A607-D34DF1E92AF5Q30487614-8043A22B-35E2-4A08-851E-2A9856E14823Q30495277-092E8221-4CA4-4F2A-AF01-76EB5408CFB1Q30540593-56BAA1DC-4D9B-43B8-85D7-AECFF7E85E32Q30570001-BDA47A16-7DE0-4D93-9246-73E513A47A0EQ33260135-52F1B42F-CEEA-4201-A1DE-E8EF59D8D1B2Q33314935-88F8AE7A-B2C9-42C8-B5C4-E225F3F2D58BQ33317751-AC5C453D-83FC-47EF-BBAB-8CBE8A4D7C7CQ33396987-CB20AA54-9AFE-4DB5-A5FA-733D40EAB10BQ33522347-7A07BD56-849E-4CCD-AE9C-962D4564F8B6Q33526747-85C3C562-603C-461C-92CC-8A27B347A1D4
P2860
Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@ast
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@en
type
label
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@ast
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@en
prefLabel
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@ast
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@en
P2093
P2860
P1476
Inhibition of human Chk1 cause ...... ATR targets, and DNA breakage
@en
P2093
Cecilia Lundin
Claus Storgaard Sørensen
Fredrik Johansson
Lasse Tengbjerg Hansen
Maxwell Sehested
Randi G Syljuåsen
P2860
P304
P356
10.1128/MCB.25.9.3553-3562.2005
P407
P577
2005-05-01T00:00:00Z